Network Insights Methodology Get Access

M&A

ORG Financials / Investment Banking & Brokerage Momentum 6.2ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. QUIETPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

M&A represents mergers and acquisitions activity across multiple sectors. Recent deal volume in healthcare, financial services, and cybersecurity reflects robust investment banking and PE-backed transaction flow in 2026.

M&A activity accelerating across healthcare (GHO-CBC tie-up), financial services, cybersecurity (Eurazeo acquisition), and private equity-backed ASC and physician transactions. Data room utilization signals growth in deal flow.
-1.04
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
6.2
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
27
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
M&A is getting less coverage than expected — the market may be ignoring a developing story (primary driver: Attention Cascade).
Connected Entities
PlocamiumAI Brazil Middle East CEO Eli Lilly Mexico United Kingdom Bloomberg Europe UnitedHealth Group Beijing European Union Germany LONDON NEW YORK
Watch This Entity
PSI Intelligence
30-Day Trend
2026-04-28 2026-05-28 27 0 Degree Mentions
Signal Decomposition
Attention Cascade
0.236
Narrative Drift
0.000
Spectral Shift
1184.899
Sentiment-Momentum Divergence
0.000
Source Concentration
0.220
Signal
M&A is getting less coverage than expected — the market may be ignoring a developing story (primary driver: Attention Cascade).
Driver
Ranked #27 of 29 in — in line with sector peers. PSI stable vs yesterday (-1.00). Confidence: 63% (entity has limited history, score is shrunk toward sector prior).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
27 of 29
Sector Rank
+0.00
Peer Z-Score
7%
Sector Percentile
Network Analysis
27 Degree Centrality
Ego Network (top connections)
PlocamiumAI (weight 16.0)Brazil (weight 11.0)Middle East (weight 5.0)CEO (weight 5.0)Eli Lilly (weight 5.0)Mexico (weight 5.0)United Kingdom (weight 4.0)Bloomberg (weight 4.0) PlocamiumAIBrazilMiddle EastCEOEli LillyMexicoUnited KingdomBloomberg M&A (degree 27) M&A
Centrality History
2026-04-28 2026-05-28 27 0 Degree Mentions
EntityWeight StatusFirst Seen
PlocamiumAI 16 NEW
Brazil 11 NEW
Middle East 5 STABLE
CEO 5 STABLE
Eli Lilly 5 NEW
Mexico 5 NEW
United Kingdom 4 STABLE
Bloomberg 4 STABLE
Europe 3 STABLE
UnitedHealth Group 3 NEW
Beijing 2 STABLE
European Union 2 STABLE
Germany 2 STABLE
LONDON 2 NEW
NEW YORK 2 STABLE
OpenAI 2 STABLE
Argentina 2 NEW
President 2 STABLE
Florida 2 NEW
Texas 2 STABLE
SpaceX 2 STABLE
Australia 2 STABLE
DRC 2 NEW
Nigeria 2 STABLE
Berkshire Hathaway 2 NEW
Japan 2 STABLE
Warren Buffett 2 NEW
Article Coverage (20)
DateLaneTitle
2026-05-27 Healthcare M&A Cencora Poaches CVS Finance Leader to Navigate Prescription Drug Pressures
2026-05-27 Industrials & Manufacturing PMGC Acquires 76-Year-Old Aerospace Supplier as Defense Reshoring Accelerates Manufacturing Consolidation
2026-05-23 Healthcare M&A Private Equity Bet on Consumer Health Accelerates as Avista Buys Sanotact
2026-05-21 Healthcare M&A Eli Lilly Acquires Engage Bio to Unlock Repeat Dosing Gene Therapies Viral Rivals Cannot Match
2026-05-16 Industrials & Manufacturing Data Center Boom Forces USG to Abandon Maintenance Mode For Aggressive Capacity Bet
2026-04-22 Healthcare M&A PE-backed Aqua Dermatology Acquires Steele Dermatology
2026-04-11 Healthcare M&A Advent, Avista, Main Post Bet on Personal Care; Underinvested Women's Health Draws in Private Equity
2026-04-09 Healthcare M&A I.M.F. Says Iran War Will Drag Global Growth Lower
2026-04-09 Healthcare M&A I.M.F. Says Iran War Will Drag Global Growth Lower
2026-04-09 Healthcare M&A I.M.F. Says Iran War Will Drag Global Growth Lower
2026-04-09 Healthcare M&A I.M.F. Says Iran War Will Drag Global Growth Lower
2026-04-09 Healthcare M&A I.M.F. Says Iran War Will Drag Global Growth Lower
2026-04-07 Healthcare M&A Blackstone and TPG Complete Take-Private Buyout of Women's Health Firm Hologic
2026-04-04 Healthcare M&A OpenLoop Health Has Acquired Nutrition Startup Season Health
2026-04-01 Geopolitics / GCC / LATAM Spanish Defence Group Chair Quits After M&A Clash With Government
2026-03-31 Healthcare M&A Biogen to Acquire Immunology Biotech Apellis For $5.6 Billion
2026-03-31 Healthcare M&A Eli Lilly to Buy Centessa Pharmaceuticals, Maker of a Narcolepsy Drug, in $6.3B Deal
2026-03-31 Healthcare M&A Eli Lilly to Buy Centessa Pharmaceuticals, Maker of a Narcolepsy Drug, in $6.3B Deal
2026-03-31 Healthcare M&A Eli Lilly to Buy Centessa Pharmaceuticals, Maker of a Narcolepsy Drug, in $6.3B Deal
2026-03-27 Healthcare M&A Novartis to Spend Up to $2B on Excellergy and Its Next-Gen Xolair Candidate

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-05-28 ← Intelligence Network